Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market
5. Voice of Customer
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application for Which PBMCs Are Used
5.4. Factors Driving Market Growth
6. Global Peripheral Blood Mononuclear Cells Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
6.2.2. By Application (Immunology, Infectious Disease, Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.6. By Company (2021)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7. North America Peripheral Blood Mononuclear Cells Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Source
7.3.2. Canada Peripheral Blood Mononuclear Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Source
7.3.3. Mexico Peripheral Blood Mononuclear Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Source
8. Europe Peripheral Blood Mononuclear Cells Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Source
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Peripheral Blood Mononuclear Cells Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Source
8.3.2. France Peripheral Blood Mononuclear Cells Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Source
8.3.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Source
8.3.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Source
8.3.5. Spain Peripheral Blood Mononuclear Cells Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Source
9. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Source
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Source
9.3.2. Japan Peripheral Blood Mononuclear Cells Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Source
9.3.3. India Peripheral Blood Mononuclear Cells Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Source
9.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By Technique
9.3.4.2.4. By Source
9.3.5. Australia Peripheral Blood Mononuclear Cells Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By Technique
9.3.5.2.4. By Source
10. South America Peripheral Blood Mononuclear Cells Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Source
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Source
10.3.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Source
10.3.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Source
11. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Application
11.2.3. By Technique
11.2.4. By Source
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Peripheral Blood Mononuclear Cells Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By Technique
11.3.1.2.4. By Source
11.3.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By Technique
11.3.2.2.4. By Source
11.3.3. South Africa Peripheral Blood Mononuclear Cells Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By Technique
11.3.3.2.4. By Source
12. Market Dynamics
12.1. Drivers
12.1.1. Growing Use in Toxicological Research
12.1.2. Increasing Usage of Peripheral Blood Mononuclear Cells for Cell Therapy
12.1.3. Increasing R&D of Peripheral Blood Mononuclear Cells for Human Well-Being
12.2. Challenges
12.2.1. High Cost of Procedure
12.2.2. Phenotypic Differences between Peripheral Mononuclear Cells and Immune Cells of the Intestinal Mucosa
12.2.3. Lack of Skilled Professionals
13. Market Trends & Developments
13.1. Use of PBMC in Treatment of Ischemic Stroke
13.2. Use of Novel Isolation Techniques
13.3. Use of Precision Medicine
13.4. PBMC in Biomarker Identification
13.5. Peripheral Blood mononuclear cell secretome for Tissue Repair
13.6. Development & Use of Fully Characterized, Ready to Use PBMCs
14. Clinical Trial Analysis
14.1. Ongoing Clinical Trials
14.2. Completed Clinical Trials
14.3. Terminated Clinical Trials
14.4. Breakdown of Pipeline, By Development Phase
14.5. Breakdown of Pipeline, By Status
14.6. Breakdown of Pipeline, By Study Type
14.7. Breakdown of Pipeline, By Region
14.8. Clinical Trials Heat Map
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (In Case of Listed Companies)
15.5. Key Personnel
15.5.1. Charles River Laboratories International, Inc.
15.5.2. Lonza Group AG
15.5.3. Corning Inc
15.5.4. Bio-Rad Laboratories Inc
15.5.5. Biolegend Inc
15.5.6. BioVision Inc
15.5.7. ZEN-Bio Inc
15.5.8. DAPCEL, Inc.
15.5.9. Creative Bioarray
15.5.10. iXCells Biotechnologies USA, LLC
15.5.11. Miltenyi Biotec B.V. & CO. KG
15.5.12. STEMCELL Technologies Inc.
15.5.13. Precision Medicine Group, LLC.
15.5.14. StemExpress, LLC
15.5.15. RayBiotech Life, Inc.
15.5.16. REPROCELL Inc.
15.5.17. Cytologics LLC
15.5.18. BioIVT LLC
15.5.19. Biopredic International
15.5.20. Cell Applications, Inc.
16. Strategic Recommendations



List of Figures


Figure 1: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 3: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 4: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 5: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 6: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Region, By Value, 2017-2027F
Figure 7: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Company, By Value, 2021
Figure 8: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Map, By Technique, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Map, By Source, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Peripheral Blood Mononuclear Cells (PBMCs) Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 14: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 15: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 16: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 17: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 18: North America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Country, By Value, 2017-2027F
Figure 19: United States Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 20: United States Number of Cell Therapy Clinical Trials Studies, 2018-2021
Figure 21: United States Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 22: United States Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 23: United States Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 24: United States Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 25: Canada Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 26: Total Health Research Expenditure in Canada (USD), 2017-2021
Figure 27: Canada Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 28: Canada Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 29: Canada Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 30: Canada Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 31: Mexico Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 32: Number of Registered Clinical Studies in Mexico As of July 2022, By Status
Figure 33: Mexico Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 34: Mexico Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 35: Mexico Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 36: Mexico Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 37: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 38: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 39: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 40: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 41: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 42: Europe Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Country, By Value, 2017-2027F
Figure 43: Germany Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 44: Germany Research & Development Expenditure as a Percentage of GDP
Figure 45: Germany Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 46: Germany Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 47: Germany Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 48: Germany Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 49: France Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 50: Percentage of New Cancer Cases in France, Both Sexes, All Ages, 2020
Figure 51: France Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 52: France Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 53: France Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 54: France Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 55: United Kingdom Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 56: Annual Expenditure on Health in United Kingdom (USD Million), 2017-2021
Figure 57: United Kingdom Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 58: United Kingdom Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 59: United Kingdom Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 60: United Kingdom Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 61: Italy Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 62: Number of Hematopoietic Stem Cell Donors in Italy (in 1,000s), 2017-2021
Figure 63: Italy Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 64: Italy Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 65: Italy Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 66: Italy Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 67: Spain Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 68: Percentage Distribution of Clinical Trials of Coronavirus Treatments Authorized in Spain in January 2021, By Type of Treatment
Figure 69: Spain Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 70: Spain Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 71: Spain Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 72: Spain Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 73: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 74: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 75: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 76: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 77: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 78: Asia Pacific Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Country, By Value, 2017-2027F
Figure 79: China Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 80: China Number of Cell Therapy Clinical Trials Studies, 2018-2021
Figure 81: China Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 82: China Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 83: China Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 84: China Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 85: Japan Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 86: Japan Research & Development Expenditure As a Percentage of GDP, 2017-2020
Figure 87: Japan Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 88: Japan Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 89: Japan Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 90: Japan Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 91: India Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 92: Number of Cases of Cerebral Stroke in Senior Citizens Across India (In Million
Figure 93: India Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 94: India Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 95: India Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 96: India Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 97: South Korea Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 98: Percentage of New Cancer Cases in South Korea, Both Sexes, All Ages, 2020
Figure 99: South Korea Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 100: South Korea Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 101: South Korea Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 102: South Korea Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 103: Australia Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 104: Australia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 105: Australia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 106: Australia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 107: Australia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 108: Singapore Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 109: Number of Clinical Trials Approved in Singapore, 2017-2022
Figure 110: Singapore Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 111: Singapore Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 112: Singapore Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 113: Singapore Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 114: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 115: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 116: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 117: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 118: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 119: South America Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Country, By Value, 2017-2027F
Figure120: Brazil Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 121: Governmental Health Expenditure in Brazil in 2021, By Area
Figure 122: Brazil Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 123: Brazil Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 124: Brazil Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 125: Brazil Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 126: Argentina Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 127: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
Figure 128: Argentina Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 129: Argentina Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 130: Argentina Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 131: Argentina Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 132: Colombia Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 133: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
Figure 134: Colombia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure135: Colombia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 136: Colombia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 137: Colombia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 138: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 139: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 140: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 141: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 142: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 143: Middle East & Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Country, By Value, 2017-2027F
Figure 144: UAE Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 145: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
Figure 146: UAE Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 147: UAE Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 148: UAE Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 149: UAE Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure150: Saudi Arabia Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 151: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
Figure 152: Saudi Arabia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 153: Saudi Arabia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 154: Saudi Arabia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 155: Saudi Arabia Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 156: South Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Size, By Value (USD Million), 2017-2027F
Figure 157: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
Figure 158: South Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Product, By Value, 2017-2027F
Figure 159: South Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Application, By Value, 2017-2027F
Figure 160: South Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Technique, By Value, 2017-2027F
Figure 161: South Africa Peripheral Blood Mononuclear Cells (PBMCs) Market Share, By Source, By Value, 2017-2027F
Figure 162: Global Percentage of Cell and Gene Therapy Clinical Trials as of 2019, Divided by Clinical Trial Phase
Figure 163: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Development Phase, 1993-2023E
Figure 164: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Status, 1993-2023E
Figure165: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Study Type, 1993-2023E
Figure 166: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Region, 1993-2023E
Figure 167: Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Year, 2017-2023E
Figure 168: Peripheral Blood Mononuclear Cells: Clinical Trials Heat Map
List of Tables:
Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia-Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia-Pacific, By Type, 2020
Table 9: Recent Gene Therapy Clinical Studies in Australia As of February 2022, By Status
Table 10: South America Cancer Statistics, 2020
Table 11: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 12: Middle East & Africa Cancer Statistics, 2020
Table 13: Total Number of New Cancer Cases and Deaths Reported in Middle East, By Type, 2020
Table 14: Pricing Analysis of PBMC Products
Table 15: Clinical Trial Analysis